カテゴリ： 世界, 医療/バイオ, QYResearch

抗感染症薬の世界市場2023年：抗菌薬、抗真菌薬、抗ウイルス薬、抗寄生虫薬

■ 英語タイトル：Global Anti-infectious Disease Drugs Market Research Report 2023

調査会社QYResearch社が発行したリサーチレポート（データ管理コード：QYR23MA8673）■ 発行会社/調査会社：QYResearch
■ 商品コード：QYR23MA8673
■ 発行日：2023年3月
■ 調査対象地域：グローバル
■ 産業分野：医薬品
■ ページ数：95
■ レポート言語：英語
■ レポート形式：PDF
■ 納品方式：Eメール（受注後2-3営業日）
■ 販売価格オプション（消費税別）
Single User（1名様閲覧用）USD2,900 ⇒換算￥440,800見積依頼/購入/質問フォーム
Multi User（5名様閲覧用）USD4,350 ⇒換算￥661,200見積依頼/購入/質問フォーム
Enterprise License（同一法人内共有可）USD5,800 ⇒換算￥881,600見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご購入に関する詳細案内はご利用ガイドでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いも可能）
※QYResearch社の概要及び新刊レポートはこちらでご確認いただけます。
★グローバルリサーチ資料[抗感染症薬の世界市場2023年：抗菌薬、抗真菌薬、抗ウイルス薬、抗寄生虫薬]についてメールでお問い合わせはこちら
*** レポート概要（サマリー）***

本調査資料は抗感染症薬のグローバル市場について調査・分析し、世界の抗感染症薬市場概要、メーカー別競争状況、地域別市場規模、タイプ別セグメント分析（抗菌薬、抗真菌薬、抗ウイルス薬、抗寄生虫薬）、用途別セグメント分析（病院、医学研究所、診療所、その他）、主要企業のプロファイル、市場動向などに関する情報を掲載しています。主要企業としては、Aridis Pharmaceuticals、AiCuris、Sandoz、Anhui Jingfang Medical Industry Co.,Ltd、Beijing Double-Crane Pharmaceutical Co., Ltd.、Abbott、Spero Therapeutics、Adlyfe, Inc.、Advanced Life Sciences Holdings, Inc.、Affinium Pharmaceuticals、APP Pharmaceuticals、Aquapharm Biodiscovery、Basilea Pharmaceutica AG、Biophage Pharma, Inc.などが含まれています。抗感染症薬のグローバル市場は、2022年にXXX米ドル、2029年にはXXX米ドルに達すると予測され、予測期間の年平均成長率はXXX％です。新型コロナとロシア・ウクライナ戦争の影響は、抗感染症薬市場規模を算出する際に考慮しました。

・抗感染症薬市場の概要
- 製品の定義
- 抗感染症薬の種類別セグメント
- 世界の抗感染症薬市場規模：タイプ別分析（抗菌薬、抗真菌薬、抗ウイルス薬、抗寄生虫薬）
- 抗感染症薬の用途別セグメント
- 世界の抗感染症薬市場規模：用途別分析（病院、医学研究所、診療所、その他）
- 世界の抗感染症薬市場規模予測（2018年-2029年）
- 抗感染症薬の平均価格推移（2018年-2029年）
- 前提条件と制限事項

・メーカー別競争状況
- メーカー別市場シェア
- 世界の主要メーカー、業界ランキング分析
- メーカー別平均価格
- 抗感染症薬市場の競争状況およびトレンド

・抗感染症薬の地域別市場規模
- 北米の抗感染症薬市場規模（2018年-2029年）
- 米国の抗感染症薬市場規模（2018年-2029年）
- ヨーロッパの抗感染症薬市場規模（2018年-2029年）
- アジア太平洋の抗感染症薬市場規模（2018年-2029年）
- 中国の抗感染症薬市場規模（2018年-2029年）
- 日本の抗感染症薬市場規模（2018年-2029年）
- 韓国の抗感染症薬市場規模（2018年-2029年）
- インドの抗感染症薬市場規模（2018年-2029年）
- オーストラリアの抗感染症薬市場規模（2018年-2029年）
- 中南米の抗感染症薬市場規模（2018年-2029年）
- 中東・アフリカの抗感染症薬市場規模（2018年-2029年）

・種類別セグメント：抗菌薬、抗真菌薬、抗ウイルス薬、抗寄生虫薬
- 世界の抗感染症薬のタイプ別販売量（2018年-2023年）
- 世界の抗感染症薬のタイプ別売上（2018年-2023年）
- 世界の抗感染症薬のタイプ別価格

・用途別セグメント：病院、医学研究所、診療所、その他
- 世界の抗感染症薬の用途別販売量（2018年-2023年）
- 世界の抗感染症薬の用途別売上（2018年-2023年）
- 世界の抗感染症薬の用途別価格

・主要企業のプロファイル：企業情報、事業概要、売上、製品ポートフォリオ、動向
Aridis Pharmaceuticals、AiCuris、Sandoz、Anhui Jingfang Medical Industry Co.,Ltd、Beijing Double-Crane Pharmaceutical Co., Ltd.、Abbott、Spero Therapeutics、Adlyfe, Inc.、Advanced Life Sciences Holdings, Inc.、Affinium Pharmaceuticals、APP Pharmaceuticals、Aquapharm Biodiscovery、Basilea Pharmaceutica AG、Biophage Pharma, Inc.

・産業チェーンと販売チャネルの分析
- 抗感染症薬産業チェーン分析
- 抗感染症薬の主要原材料
- 抗感染症薬の販売チャネル
- 抗感染症薬のディストリビューター
- 抗感染症薬の主要顧客

・抗感染症薬市場ダイナミクス
- 抗感染症薬の業界動向
- 抗感染症薬市場の成長ドライバ、課題、阻害要因

・調査の結論

・調査手法と情報源

Highlights
The global Anti-infectious Disease Drugs market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Netherlands-Ukraine War were considered while estimating market sizes.
North American market for Anti-infectious Disease Drugs is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
Asia-Pacific market for Anti-infectious Disease Drugs is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The key global manufacturers of Anti-infectious Disease Drugs include Aridis Pharmaceuticals, AiCuris, Sandoz, Anhui Jingfang Medical Industry Co.,Ltd, Beijing Double-Crane Pharmaceutical Co., Ltd., Abbott, Spero Therapeutics, Adlyfe, Inc. and Advanced Life Sciences Holdings, Inc., etc. in 2022, the world’s top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Anti-infectious Disease Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Anti-infectious Disease Drugs.
The Anti-infectious Disease Drugs market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Anti-infectious Disease Drugs market comprehensively. Regional market sizes, concerning products by type, by application and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Anti-infectious Disease Drugs manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by type, by application and by regions.
By Company
Aridis Pharmaceuticals
AiCuris
Sandoz
Anhui Jingfang Medical Industry Co.,Ltd
Beijing Double-Crane Pharmaceutical Co., Ltd.
Abbott
Spero Therapeutics
Adlyfe, Inc.
Advanced Life Sciences Holdings, Inc.
Affinium Pharmaceuticals
APP Pharmaceuticals
Aquapharm Biodiscovery
Basilea Pharmaceutica AG
Biophage Pharma, Inc.
Segment by Type
Antibacterial Drugs
Antifungal Drugs
Antiviral Drugs
Antiparasitic Drugs
Segment by Application
Hospital
Institute of Medicine
Clinic
Others
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Anti-infectious Disease Drugs manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Anti-infectious Disease Drugs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the key companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.

*** レポート目次（コンテンツ）***

1 Anti-infectious Disease Drugs Market Overview
1.1 Product Overview and Scope of Anti-infectious Disease Drugs
1.2 Anti-infectious Disease Drugs Segment by Type
1.2.1 Global Anti-infectious Disease Drugs Market Value Comparison by Type (2023-2029)
1.2.2 Antibacterial Drugs
1.2.3 Antifungal Drugs
1.2.4 Antiviral Drugs
1.2.5 Antiparasitic Drugs
1.3 Anti-infectious Disease Drugs Segment by Application
1.3.1 Global Anti-infectious Disease Drugs Market Value by Application: (2023-2029)
1.3.2 Hospital
1.3.3 Institute of Medicine
1.3.4 Clinic
1.3.5 Others
1.4 Global Anti-infectious Disease Drugs Market Size Estimates and Forecasts
1.4.1 Global Anti-infectious Disease Drugs Revenue 2018-2029
1.4.2 Global Anti-infectious Disease Drugs Sales 2018-2029
1.4.3 Global Anti-infectious Disease Drugs Market Average Price (2018-2029)
1.5 Assumptions and Limitations
2 Anti-infectious Disease Drugs Market Competition by Manufacturers
2.1 Global Anti-infectious Disease Drugs Sales Market Share by Manufacturers (2018-2023)
2.2 Global Anti-infectious Disease Drugs Revenue Market Share by Manufacturers (2018-2023)
2.3 Global Anti-infectious Disease Drugs Average Price by Manufacturers (2018-2023)
2.4 Global Anti-infectious Disease Drugs Industry Ranking 2021 VS 2022 VS 2023
2.5 Global Key Manufacturers of Anti-infectious Disease Drugs, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Anti-infectious Disease Drugs, Product Type & Application
2.7 Anti-infectious Disease Drugs Market Competitive Situation and Trends
2.7.1 Anti-infectious Disease Drugs Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Anti-infectious Disease Drugs Players Market Share by Revenue
2.7.3 Global Anti-infectious Disease Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Anti-infectious Disease Drugs Retrospective Market Scenario by Region
3.1 Global Anti-infectious Disease Drugs Market Size by Region: 2018 Versus 2022 Versus 2029
3.2 Global Anti-infectious Disease Drugs Global Anti-infectious Disease Drugs Sales by Region: 2018-2029
3.2.1 Global Anti-infectious Disease Drugs Sales by Region: 2018-2023
3.2.2 Global Anti-infectious Disease Drugs Sales by Region: 2024-2029
3.3 Global Anti-infectious Disease Drugs Global Anti-infectious Disease Drugs Revenue by Region: 2018-2029
3.3.1 Global Anti-infectious Disease Drugs Revenue by Region: 2018-2023
3.3.2 Global Anti-infectious Disease Drugs Revenue by Region: 2024-2029
3.4 North America Anti-infectious Disease Drugs Market Facts & Figures by Country
3.4.1 North America Anti-infectious Disease Drugs Market Size by Country: 2018 VS 2022 VS 2029
3.4.2 North America Anti-infectious Disease Drugs Sales by Country (2018-2029)
3.4.3 North America Anti-infectious Disease Drugs Revenue by Country (2018-2029)
3.4.4 United States
3.4.5 Canada
3.5 Europe Anti-infectious Disease Drugs Market Facts & Figures by Country
3.5.1 Europe Anti-infectious Disease Drugs Market Size by Country: 2018 VS 2022 VS 2029
3.5.2 Europe Anti-infectious Disease Drugs Sales by Country (2018-2029)
3.5.3 Europe Anti-infectious Disease Drugs Revenue by Country (2018-2029)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Anti-infectious Disease Drugs Market Facts & Figures by Country
3.6.1 Asia Pacific Anti-infectious Disease Drugs Market Size by Country: 2018 VS 2022 VS 2029
3.6.2 Asia Pacific Anti-infectious Disease Drugs Sales by Country (2018-2029)
3.6.3 Asia Pacific Anti-infectious Disease Drugs Revenue by Country (2018-2029)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Anti-infectious Disease Drugs Market Facts & Figures by Country
3.7.1 Latin America Anti-infectious Disease Drugs Market Size by Country: 2018 VS 2022 VS 2029
3.7.2 Latin America Anti-infectious Disease Drugs Sales by Country (2018-2029)
3.7.3 Latin America Anti-infectious Disease Drugs Revenue by Country (2018-2029)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Anti-infectious Disease Drugs Market Facts & Figures by Country
3.8.1 Middle East and Africa Anti-infectious Disease Drugs Market Size by Country: 2018 VS 2022 VS 2029
3.8.2 Middle East and Africa Anti-infectious Disease Drugs Sales by Country (2018-2029)
3.8.3 Middle East and Africa Anti-infectious Disease Drugs Revenue by Country (2018-2029)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Anti-infectious Disease Drugs Sales by Type (2018-2029)
4.1.1 Global Anti-infectious Disease Drugs Sales by Type (2018-2023)
4.1.2 Global Anti-infectious Disease Drugs Sales by Type (2024-2029)
4.1.3 Global Anti-infectious Disease Drugs Sales Market Share by Type (2018-2029)
4.2 Global Anti-infectious Disease Drugs Revenue by Type (2018-2029)
4.2.1 Global Anti-infectious Disease Drugs Revenue by Type (2018-2023)
4.2.2 Global Anti-infectious Disease Drugs Revenue by Type (2024-2029)
4.2.3 Global Anti-infectious Disease Drugs Revenue Market Share by Type (2018-2029)
4.3 Global Anti-infectious Disease Drugs Price by Type (2018-2029)
5 Segment by Application
5.1 Global Anti-infectious Disease Drugs Sales by Application (2018-2029)
5.1.1 Global Anti-infectious Disease Drugs Sales by Application (2018-2023)
5.1.2 Global Anti-infectious Disease Drugs Sales by Application (2024-2029)
5.1.3 Global Anti-infectious Disease Drugs Sales Market Share by Application (2018-2029)
5.2 Global Anti-infectious Disease Drugs Revenue by Application (2018-2029)
5.2.1 Global Anti-infectious Disease Drugs Revenue by Application (2018-2023)
5.2.2 Global Anti-infectious Disease Drugs Revenue by Application (2024-2029)
5.2.3 Global Anti-infectious Disease Drugs Revenue Market Share by Application (2018-2029)
5.3 Global Anti-infectious Disease Drugs Price by Application (2018-2029)
6 Key Companies Profiled
6.1 Aridis Pharmaceuticals
6.1.1 Aridis Pharmaceuticals Corporation Information
6.1.2 Aridis Pharmaceuticals Description and Business Overview
6.1.3 Aridis Pharmaceuticals Anti-infectious Disease Drugs Sales, Revenue and Gross Margin (2018-2023)
6.1.4 Aridis Pharmaceuticals Anti-infectious Disease Drugs Product Portfolio
6.1.5 Aridis Pharmaceuticals Recent Developments/Updates
6.2 AiCuris
6.2.1 AiCuris Corporation Information
6.2.2 AiCuris Description and Business Overview
6.2.3 AiCuris Anti-infectious Disease Drugs Sales, Revenue and Gross Margin (2018-2023)
6.2.4 AiCuris Anti-infectious Disease Drugs Product Portfolio
6.2.5 AiCuris Recent Developments/Updates
6.3 Sandoz
6.3.1 Sandoz Corporation Information
6.3.2 Sandoz Description and Business Overview
6.3.3 Sandoz Anti-infectious Disease Drugs Sales, Revenue and Gross Margin (2018-2023)
6.3.4 Sandoz Anti-infectious Disease Drugs Product Portfolio
6.3.5 Sandoz Recent Developments/Updates
6.4 Anhui Jingfang Medical Industry Co.,Ltd
6.4.1 Anhui Jingfang Medical Industry Co.,Ltd Corporation Information
6.4.2 Anhui Jingfang Medical Industry Co.,Ltd Description and Business Overview
6.4.3 Anhui Jingfang Medical Industry Co.,Ltd Anti-infectious Disease Drugs Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Anhui Jingfang Medical Industry Co.,Ltd Anti-infectious Disease Drugs Product Portfolio
6.4.5 Anhui Jingfang Medical Industry Co.,Ltd Recent Developments/Updates
6.5 Beijing Double-Crane Pharmaceutical Co., Ltd.
6.5.1 Beijing Double-Crane Pharmaceutical Co., Ltd. Corporation Information
6.5.2 Beijing Double-Crane Pharmaceutical Co., Ltd. Description and Business Overview
6.5.3 Beijing Double-Crane Pharmaceutical Co., Ltd. Anti-infectious Disease Drugs Sales, Revenue and Gross Margin (2018-2023)
6.5.4 Beijing Double-Crane Pharmaceutical Co., Ltd. Anti-infectious Disease Drugs Product Portfolio
6.5.5 Beijing Double-Crane Pharmaceutical Co., Ltd. Recent Developments/Updates
6.6 Abbott
6.6.1 Abbott Corporation Information
6.6.2 Abbott Description and Business Overview
6.6.3 Abbott Anti-infectious Disease Drugs Sales, Revenue and Gross Margin (2018-2023)
6.6.4 Abbott Anti-infectious Disease Drugs Product Portfolio
6.6.5 Abbott Recent Developments/Updates
6.7 Spero Therapeutics
6.6.1 Spero Therapeutics Corporation Information
6.6.2 Spero Therapeutics Description and Business Overview
6.6.3 Spero Therapeutics Anti-infectious Disease Drugs Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Spero Therapeutics Anti-infectious Disease Drugs Product Portfolio
6.7.5 Spero Therapeutics Recent Developments/Updates
6.8 Adlyfe, Inc.
6.8.1 Adlyfe, Inc. Corporation Information
6.8.2 Adlyfe, Inc. Description and Business Overview
6.8.3 Adlyfe, Inc. Anti-infectious Disease Drugs Sales, Revenue and Gross Margin (2018-2023)
6.8.4 Adlyfe, Inc. Anti-infectious Disease Drugs Product Portfolio
6.8.5 Adlyfe, Inc. Recent Developments/Updates
6.9 Advanced Life Sciences Holdings, Inc.
6.9.1 Advanced Life Sciences Holdings, Inc. Corporation Information
6.9.2 Advanced Life Sciences Holdings, Inc. Description and Business Overview
6.9.3 Advanced Life Sciences Holdings, Inc. Anti-infectious Disease Drugs Sales, Revenue and Gross Margin (2018-2023)
6.9.4 Advanced Life Sciences Holdings, Inc. Anti-infectious Disease Drugs Product Portfolio
6.9.5 Advanced Life Sciences Holdings, Inc. Recent Developments/Updates
6.10 Affinium Pharmaceuticals
6.10.1 Affinium Pharmaceuticals Corporation Information
6.10.2 Affinium Pharmaceuticals Description and Business Overview
6.10.3 Affinium Pharmaceuticals Anti-infectious Disease Drugs Sales, Revenue and Gross Margin (2018-2023)
6.10.4 Affinium Pharmaceuticals Anti-infectious Disease Drugs Product Portfolio
6.10.5 Affinium Pharmaceuticals Recent Developments/Updates
6.11 APP Pharmaceuticals
6.11.1 APP Pharmaceuticals Corporation Information
6.11.2 APP Pharmaceuticals Anti-infectious Disease Drugs Description and Business Overview
6.11.3 APP Pharmaceuticals Anti-infectious Disease Drugs Sales, Revenue and Gross Margin (2018-2023)
6.11.4 APP Pharmaceuticals Anti-infectious Disease Drugs Product Portfolio
6.11.5 APP Pharmaceuticals Recent Developments/Updates
6.12 Aquapharm Biodiscovery
6.12.1 Aquapharm Biodiscovery Corporation Information
6.12.2 Aquapharm Biodiscovery Anti-infectious Disease Drugs Description and Business Overview
6.12.3 Aquapharm Biodiscovery Anti-infectious Disease Drugs Sales, Revenue and Gross Margin (2018-2023)
6.12.4 Aquapharm Biodiscovery Anti-infectious Disease Drugs Product Portfolio
6.12.5 Aquapharm Biodiscovery Recent Developments/Updates
6.13 Basilea Pharmaceutica AG
6.13.1 Basilea Pharmaceutica AG Corporation Information
6.13.2 Basilea Pharmaceutica AG Anti-infectious Disease Drugs Description and Business Overview
6.13.3 Basilea Pharmaceutica AG Anti-infectious Disease Drugs Sales, Revenue and Gross Margin (2018-2023)
6.13.4 Basilea Pharmaceutica AG Anti-infectious Disease Drugs Product Portfolio
6.13.5 Basilea Pharmaceutica AG Recent Developments/Updates
6.14 Biophage Pharma, Inc.
6.14.1 Biophage Pharma, Inc. Corporation Information
6.14.2 Biophage Pharma, Inc. Anti-infectious Disease Drugs Description and Business Overview
6.14.3 Biophage Pharma, Inc. Anti-infectious Disease Drugs Sales, Revenue and Gross Margin (2018-2023)
6.14.4 Biophage Pharma, Inc. Anti-infectious Disease Drugs Product Portfolio
6.14.5 Biophage Pharma, Inc. Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Anti-infectious Disease Drugs Industry Chain Analysis
7.2 Anti-infectious Disease Drugs Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Anti-infectious Disease Drugs Production Mode & Process
7.4 Anti-infectious Disease Drugs Sales and Marketing
7.4.1 Anti-infectious Disease Drugs Sales Channels
7.4.2 Anti-infectious Disease Drugs Distributors
7.5 Anti-infectious Disease Drugs Customers
8 Anti-infectious Disease Drugs Market Dynamics
8.1 Anti-infectious Disease Drugs Industry Trends
8.2 Anti-infectious Disease Drugs Market Drivers
8.3 Anti-infectious Disease Drugs Market Challenges
8.4 Anti-infectious Disease Drugs Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer

List of Tables
Table 1. Global Anti-infectious Disease Drugs Market Value Comparison by Type (2023-2029) & (US$ Million)
Table 2. Global Anti-infectious Disease Drugs Market Value Comparison by Application (2023-2029) & (US$ Million)
Table 3. Global Anti-infectious Disease Drugs Market Competitive Situation by Manufacturers in 2022
Table 4. Global Anti-infectious Disease Drugs Sales (K Units) of Key Manufacturers (2018-2023)
Table 5. Global Anti-infectious Disease Drugs Sales Market Share by Manufacturers (2018-2023)
Table 6. Global Anti-infectious Disease Drugs Revenue (US$ Million) by Manufacturers (2018-2023)
Table 7. Global Anti-infectious Disease Drugs Revenue Share by Manufacturers (2018-2023)
Table 8. Global Market Anti-infectious Disease Drugs Average Price (US$/Unit) of Key Manufacturers (2018-2023)
Table 9. Global Key Players of Anti-infectious Disease Drugs, Industry Ranking, 2021 VS 2022 VS 2023
Table 10. Global Key Manufacturers of Anti-infectious Disease Drugs, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Anti-infectious Disease Drugs, Product Type & Application
Table 12. Global Key Manufacturers of Anti-infectious Disease Drugs, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Anti-infectious Disease Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Anti-infectious Disease Drugs as of 2022)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Anti-infectious Disease Drugs Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 17. Global Anti-infectious Disease Drugs Sales by Region (2018-2023) & (K Units)
Table 18. Global Anti-infectious Disease Drugs Sales Market Share by Region (2018-2023)
Table 19. Global Anti-infectious Disease Drugs Sales by Region (2024-2029) & (K Units)
Table 20. Global Anti-infectious Disease Drugs Sales Market Share by Region (2024-2029)
Table 21. Global Anti-infectious Disease Drugs Revenue by Region (2018-2023) & (US$ Million)
Table 22. Global Anti-infectious Disease Drugs Revenue Market Share by Region (2018-2023)
Table 23. Global Anti-infectious Disease Drugs Revenue by Region (2024-2029) & (US$ Million)
Table 24. Global Anti-infectious Disease Drugs Revenue Market Share by Region (2024-2029)
Table 25. North America Anti-infectious Disease Drugs Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 26. North America Anti-infectious Disease Drugs Sales by Country (2018-2023) & (K Units)
Table 27. North America Anti-infectious Disease Drugs Sales by Country (2024-2029) & (K Units)
Table 28. North America Anti-infectious Disease Drugs Revenue by Country (2018-2023) & (US$ Million)
Table 29. North America Anti-infectious Disease Drugs Revenue by Country (2024-2029) & (US$ Million)
Table 30. Europe Anti-infectious Disease Drugs Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 31. Europe Anti-infectious Disease Drugs Sales by Country (2018-2023) & (K Units)
Table 32. Europe Anti-infectious Disease Drugs Sales by Country (2024-2029) & (K Units)
Table 33. Europe Anti-infectious Disease Drugs Revenue by Country (2018-2023) & (US$ Million)
Table 34. Europe Anti-infectious Disease Drugs Revenue by Country (2024-2029) & (US$ Million)
Table 35. Asia Pacific Anti-infectious Disease Drugs Revenue by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 36. Asia Pacific Anti-infectious Disease Drugs Sales by Region (2018-2023) & (K Units)
Table 37. Asia Pacific Anti-infectious Disease Drugs Sales by Region (2024-2029) & (K Units)
Table 38. Asia Pacific Anti-infectious Disease Drugs Revenue by Region (2018-2023) & (US$ Million)
Table 39. Asia Pacific Anti-infectious Disease Drugs Revenue by Region (2024-2029) & (US$ Million)
Table 40. Latin America Anti-infectious Disease Drugs Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 41. Latin America Anti-infectious Disease Drugs Sales by Country (2018-2023) & (K Units)
Table 42. Latin America Anti-infectious Disease Drugs Sales by Country (2024-2029) & (K Units)
Table 43. Latin America Anti-infectious Disease Drugs Revenue by Country (2018-2023) & (US$ Million)
Table 44. Latin America Anti-infectious Disease Drugs Revenue by Country (2024-2029) & (US$ Million)
Table 45. Middle East & Africa Anti-infectious Disease Drugs Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 46. Middle East & Africa Anti-infectious Disease Drugs Sales by Country (2018-2023) & (K Units)
Table 47. Middle East & Africa Anti-infectious Disease Drugs Sales by Country (2024-2029) & (K Units)
Table 48. Middle East & Africa Anti-infectious Disease Drugs Revenue by Country (2018-2023) & (US$ Million)
Table 49. Middle East & Africa Anti-infectious Disease Drugs Revenue by Country (2024-2029) & (US$ Million)
Table 50. Global Anti-infectious Disease Drugs Sales (K Units) by Type (2018-2023)
Table 51. Global Anti-infectious Disease Drugs Sales (K Units) by Type (2024-2029)
Table 52. Global Anti-infectious Disease Drugs Sales Market Share by Type (2018-2023)
Table 53. Global Anti-infectious Disease Drugs Sales Market Share by Type (2024-2029)
Table 54. Global Anti-infectious Disease Drugs Revenue (US$ Million) by Type (2018-2023)
Table 55. Global Anti-infectious Disease Drugs Revenue (US$ Million) by Type (2024-2029)
Table 56. Global Anti-infectious Disease Drugs Revenue Market Share by Type (2018-2023)
Table 57. Global Anti-infectious Disease Drugs Revenue Market Share by Type (2024-2029)
Table 58. Global Anti-infectious Disease Drugs Price (US$/Unit) by Type (2018-2023)
Table 59. Global Anti-infectious Disease Drugs Price (US$/Unit) by Type (2024-2029)
Table 60. Global Anti-infectious Disease Drugs Sales (K Units) by Application (2018-2023)
Table 61. Global Anti-infectious Disease Drugs Sales (K Units) by Application (2024-2029)
Table 62. Global Anti-infectious Disease Drugs Sales Market Share by Application (2018-2023)
Table 63. Global Anti-infectious Disease Drugs Sales Market Share by Application (2024-2029)
Table 64. Global Anti-infectious Disease Drugs Revenue (US$ Million) by Application (2018-2023)
Table 65. Global Anti-infectious Disease Drugs Revenue (US$ Million) by Application (2024-2029)
Table 66. Global Anti-infectious Disease Drugs Revenue Market Share by Application (2018-2023)
Table 67. Global Anti-infectious Disease Drugs Revenue Market Share by Application (2024-2029)
Table 68. Global Anti-infectious Disease Drugs Price (US$/Unit) by Application (2018-2023)
Table 69. Global Anti-infectious Disease Drugs Price (US$/Unit) by Application (2024-2029)
Table 70. Aridis Pharmaceuticals Corporation Information
Table 71. Aridis Pharmaceuticals Description and Business Overview
Table 72. Aridis Pharmaceuticals Anti-infectious Disease Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 73. Aridis Pharmaceuticals Anti-infectious Disease Drugs Product
Table 74. Aridis Pharmaceuticals Recent Developments/Updates
Table 75. AiCuris Corporation Information
Table 76. AiCuris Description and Business Overview
Table 77. AiCuris Anti-infectious Disease Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 78. AiCuris Anti-infectious Disease Drugs Product
Table 79. AiCuris Recent Developments/Updates
Table 80. Sandoz Corporation Information
Table 81. Sandoz Description and Business Overview
Table 82. Sandoz Anti-infectious Disease Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 83. Sandoz Anti-infectious Disease Drugs Product
Table 84. Sandoz Recent Developments/Updates
Table 85. Anhui Jingfang Medical Industry Co.,Ltd Corporation Information
Table 86. Anhui Jingfang Medical Industry Co.,Ltd Description and Business Overview
Table 87. Anhui Jingfang Medical Industry Co.,Ltd Anti-infectious Disease Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 88. Anhui Jingfang Medical Industry Co.,Ltd Anti-infectious Disease Drugs Product
Table 89. Anhui Jingfang Medical Industry Co.,Ltd Recent Developments/Updates
Table 90. Beijing Double-Crane Pharmaceutical Co., Ltd. Corporation Information
Table 91. Beijing Double-Crane Pharmaceutical Co., Ltd. Description and Business Overview
Table 92. Beijing Double-Crane Pharmaceutical Co., Ltd. Anti-infectious Disease Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 93. Beijing Double-Crane Pharmaceutical Co., Ltd. Anti-infectious Disease Drugs Product
Table 94. Beijing Double-Crane Pharmaceutical Co., Ltd. Recent Developments/Updates
Table 95. Abbott Corporation Information
Table 96. Abbott Description and Business Overview
Table 97. Abbott Anti-infectious Disease Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 98. Abbott Anti-infectious Disease Drugs Product
Table 99. Abbott Recent Developments/Updates
Table 100. Spero Therapeutics Corporation Information
Table 101. Spero Therapeutics Description and Business Overview
Table 102. Spero Therapeutics Anti-infectious Disease Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 103. Spero Therapeutics Anti-infectious Disease Drugs Product
Table 104. Spero Therapeutics Recent Developments/Updates
Table 105. Adlyfe, Inc. Corporation Information
Table 106. Adlyfe, Inc. Description and Business Overview
Table 107. Adlyfe, Inc. Anti-infectious Disease Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 108. Adlyfe, Inc. Anti-infectious Disease Drugs Product
Table 109. Adlyfe, Inc. Recent Developments/Updates
Table 110. Advanced Life Sciences Holdings, Inc. Corporation Information
Table 111. Advanced Life Sciences Holdings, Inc. Description and Business Overview
Table 112. Advanced Life Sciences Holdings, Inc. Anti-infectious Disease Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 113. Advanced Life Sciences Holdings, Inc. Anti-infectious Disease Drugs Product
Table 114. Advanced Life Sciences Holdings, Inc. Recent Developments/Updates
Table 115. Affinium Pharmaceuticals Corporation Information
Table 116. Affinium Pharmaceuticals Description and Business Overview
Table 117. Affinium Pharmaceuticals Anti-infectious Disease Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 118. Affinium Pharmaceuticals Anti-infectious Disease Drugs Product
Table 119. Affinium Pharmaceuticals Recent Developments/Updates
Table 120. APP Pharmaceuticals Corporation Information
Table 121. APP Pharmaceuticals Description and Business Overview
Table 122. APP Pharmaceuticals Anti-infectious Disease Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 123. APP Pharmaceuticals Anti-infectious Disease Drugs Product
Table 124. APP Pharmaceuticals Recent Developments/Updates
Table 125. Aquapharm Biodiscovery Corporation Information
Table 126. Aquapharm Biodiscovery Description and Business Overview
Table 127. Aquapharm Biodiscovery Anti-infectious Disease Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 128. Aquapharm Biodiscovery Anti-infectious Disease Drugs Product
Table 129. Aquapharm Biodiscovery Recent Developments/Updates
Table 130. Basilea Pharmaceutica AG Corporation Information
Table 131. Basilea Pharmaceutica AG Description and Business Overview
Table 132. Basilea Pharmaceutica AG Anti-infectious Disease Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 133. Basilea Pharmaceutica AG Anti-infectious Disease Drugs Product
Table 134. Basilea Pharmaceutica AG Recent Developments/Updates
Table 135. Biophage Pharma, Inc. Corporation Information
Table 136. Biophage Pharma, Inc. Description and Business Overview
Table 137. Biophage Pharma, Inc. Anti-infectious Disease Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 138. Biophage Pharma, Inc. Anti-infectious Disease Drugs Product
Table 139. Biophage Pharma, Inc. Recent Developments/Updates
Table 140. Key Raw Materials Lists
Table 141. Raw Materials Key Suppliers Lists
Table 142. Anti-infectious Disease Drugs Distributors List
Table 143. Anti-infectious Disease Drugs Customers List
Table 144. Anti-infectious Disease Drugs Market Trends
Table 145. Anti-infectious Disease Drugs Market Drivers
Table 146. Anti-infectious Disease Drugs Market Challenges
Table 147. Anti-infectious Disease Drugs Market Restraints
Table 148. Research Programs/Design for This Report
Table 149. Key Data Information from Secondary Sources
Table 150. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Anti-infectious Disease Drugs
Figure 2. Global Anti-infectious Disease Drugs Market Value Comparison by Type (2023-2029) & (US$ Million)
Figure 3. Global Anti-infectious Disease Drugs Market Share by Type in 2022 & 2029
Figure 4. Antibacterial Drugs Product Picture
Figure 5. Antifungal Drugs Product Picture
Figure 6. Antiviral Drugs Product Picture
Figure 7. Antiparasitic Drugs Product Picture
Figure 8. Global Anti-infectious Disease Drugs Market Value Comparison by Application (2023-2029) & (US$ Million)
Figure 9. Global Anti-infectious Disease Drugs Market Share by Application in 2022 & 2029
Figure 10. Hospital
Figure 11. Institute of Medicine
Figure 12. Clinic
Figure 13. Others
Figure 14. Global Anti-infectious Disease Drugs Revenue, (US$ Million), 2018 VS 2022 VS 2029
Figure 15. Global Anti-infectious Disease Drugs Market Size (2018-2029) & (US$ Million)
Figure 16. Global Anti-infectious Disease Drugs Sales (2018-2029) & (K Units)
Figure 17. Global Anti-infectious Disease Drugs Average Price (US$/Unit) & (2018-2029)
Figure 18. Anti-infectious Disease Drugs Report Years Considered
Figure 19. Anti-infectious Disease Drugs Sales Share by Manufacturers in 2022
Figure 20. Global Anti-infectious Disease Drugs Revenue Share by Manufacturers in 2022
Figure 21. The Global 5 and 10 Largest Anti-infectious Disease Drugs Players: Market Share by Revenue in 2022
Figure 22. Anti-infectious Disease Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2018 VS 2022
Figure 23. Global Anti-infectious Disease Drugs Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Figure 24. North America Anti-infectious Disease Drugs Sales Market Share by Country (2018-2029)
Figure 25. North America Anti-infectious Disease Drugs Revenue Market Share by Country (2018-2029)
Figure 26. United States Anti-infectious Disease Drugs Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 27. Canada Anti-infectious Disease Drugs Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 28. Europe Anti-infectious Disease Drugs Sales Market Share by Country (2018-2029)
Figure 29. Europe Anti-infectious Disease Drugs Revenue Market Share by Country (2018-2029)
Figure 30. Germany Anti-infectious Disease Drugs Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 31. France Anti-infectious Disease Drugs Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 32. U.K. Anti-infectious Disease Drugs Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 33. Italy Anti-infectious Disease Drugs Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 34. Russia Anti-infectious Disease Drugs Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 35. Asia Pacific Anti-infectious Disease Drugs Sales Market Share by Region (2018-2029)
Figure 36. Asia Pacific Anti-infectious Disease Drugs Revenue Market Share by Region (2018-2029)
Figure 37. China Anti-infectious Disease Drugs Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 38. Japan Anti-infectious Disease Drugs Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 39. South Korea Anti-infectious Disease Drugs Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 40. India Anti-infectious Disease Drugs Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 41. Australia Anti-infectious Disease Drugs Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 42. China Taiwan Anti-infectious Disease Drugs Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 43. Indonesia Anti-infectious Disease Drugs Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 44. Thailand Anti-infectious Disease Drugs Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 45. Malaysia Anti-infectious Disease Drugs Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 46. Latin America Anti-infectious Disease Drugs Sales Market Share by Country (2018-2029)
Figure 47. Latin America Anti-infectious Disease Drugs Revenue Market Share by Country (2018-2029)
Figure 48. Mexico Anti-infectious Disease Drugs Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 49. Brazil Anti-infectious Disease Drugs Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 50. Argentina Anti-infectious Disease Drugs Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 51. Middle East & Africa Anti-infectious Disease Drugs Sales Market Share by Country (2018-2029)
Figure 52. Middle East & Africa Anti-infectious Disease Drugs Revenue Market Share by Country (2018-2029)
Figure 53. Turkey Anti-infectious Disease Drugs Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 54. Saudi Arabia Anti-infectious Disease Drugs Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 55. UAE Anti-infectious Disease Drugs Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 56. Global Sales Market Share of Anti-infectious Disease Drugs by Type (2018-2029)
Figure 57. Global Revenue Market Share of Anti-infectious Disease Drugs by Type (2018-2029)
Figure 58. Global Anti-infectious Disease Drugs Price (US$/Unit) by Type (2018-2029)
Figure 59. Global Sales Market Share of Anti-infectious Disease Drugs by Application (2018-2029)
Figure 60. Global Revenue Market Share of Anti-infectious Disease Drugs by Application (2018-2029)
Figure 61. Global Anti-infectious Disease Drugs Price (US$/Unit) by Application (2018-2029)
Figure 62. Anti-infectious Disease Drugs Value Chain
Figure 63. Anti-infectious Disease Drugs Production Process
Figure 64. Channels of Distribution (Direct Vs Distribution)
Figure 65. Distributors Profiles
Figure 66. Bottom-up and Top-down Approaches for This Report
Figure 67. Data Triangulation
Figure 68. Key Executives Interviewed


*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/
※関連調査資料
  • 循環器疾患看護薬の世界市場2023年：降圧薬、抗狭心症薬、抗凝固薬、抗高脂血症薬、抗心不全薬、抗不整脈薬
  • クローン病治療薬のグローバル市場展望 2023年-2029年：抗炎症剤、免疫系抑制剤、抗生物質、その他
  • 世界の感染症POC診断市場2022年：市場規模予測（～2028年）
  • 抗VEGT薬のグローバル市場展望 2023年-2029年：チロシンキナーゼ阻害剤、モノクローナル抗体、その他
  • 虚血性心疾患治療薬のグローバル市場展望 2023年-2029年：狭心症、心筋梗塞
    • ※注目の調査資料
     ※当サイト上のレポートデータは弊社H&Iグローバルリサーチ運営のMarketReport.jpサイトと連動しています。
    ※当市場調査資料(QYR23MA8673 )"抗感染症薬の世界市場2023年：抗菌薬、抗真菌薬、抗ウイルス薬、抗寄生虫薬" (英文：Global Anti-infectious Disease Drugs Market Research Report 2023)はQYResearch社が調査・発行しており、H&Iグローバルリサーチが販売します。

    ◆H&Iグローバルリサーチのお客様（例）◆


    ※当サイトに掲載していない調査資料も弊社を通してご購入可能ですので、お気軽にご連絡ください。ウェブサイトでは紹介しきれない資料も数多くございます。
    ※無料翻訳ツールをご利用いただけます。翻訳可能なPDF納品ファイルが対象です。ご利用を希望されるお客様はご注文の時にその旨をお申し出ください。